Tigermed Consulting Launches 1 Billion Yuan Stock Buyback

MT NewswiresMay 13 22:33 ET

Express News | Hangzhou Tigermed Consulting - Clarifies 2 Controlling Shareholders Made Corresponding Announcements on All Previous Reduction of Shareholding

ReutersMay 13 07:58 ET

Express News | Hangzhou Tigermed Consulting - Noted Speculation as to if 2 Directors & Controlling Shareholders Made Public Announcements, Disclosures as Required

ReutersMay 13 07:57 ET

Tigermed (03347) plans to repurchase A-share stocks worth between 500 million and 1 billion yuan.

Tigermed (03347) announced that, in order to promote the company's long-term stable and healthy development, enhance investor confidence in the company, protect the interests of a wide range of investors, and further improve the company’s long-term incentive mechanism, based on recognition of the company’s future prospects and intrinsic value, it plans to repurchase some of its A-share stocks using its own funds or raised capital through centralized bidding or other methods permitted by laws and regulations. The repurchased shares will be used for implementing an A-share equity incentive plan or an A-share employee stock ownership plan, as well as reducing the company's registered capital.

Zhitong FinanceMay 13 07:34 ET

Wanlian Securities: Public equity allocations in pharmaceuticals concentrated towards the innovation industrial chain in Q1 2026. It is recommended to focus on biotechnology companies and large pharmaceutical enterprises.

The percentage of total market value held in the pharmaceuticals and biotechnology sector increased by 0.90 percentage points from the previous period. The total market value of holdings in biologics and medical services saw a significant increase. Public funds continued to concentrate their pharmaceutical investments in innovative drug development and CXO-related innovative industrial chains.

Zhitong FinanceMay 12 22:15 ET

Tigermed's stock price fell as its actual controller was investigated by the CSRC for violations related to information disclosure.

Tigermed (03347) plummeted over 9% in early trading. As of the latest update, it has dropped by 8.26%, trading at HKD 34.88, with a turnover of HKD 84.3104 million.

Zhitong FinanceMay 12 21:52 ET